Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Alcolea

Showing results (11-20 of 241) with videos related to

Pageof 25
Sort By:
Alzheimer'S Research & Therapy|October 29, 2023
Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer's disease continuumJulie Goossens, Alba Cervantes González, Nele Dewit, et al.
The Lancet. Healthy Longevity|October 6, 2024
Challenges in the practical implementation of blood biomarkers for Alzheimer's diseaseMichael Schöll, Inge M W Verberk, Marta Del Campo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 6, 2016
Longitudinal brain structural changes in preclinical Alzheimer's diseaseJordi Pegueroles, Eduard Vilaplana, Victor Montal, et al.
Critical Reviews in Clinical Laboratory Sciences|October 30, 2019
Detection of amyloid beta peptides in body fluids for the diagnosis of alzheimer's disease: Where do we stand?Bhavana Veerabhadrappa, Constance Delaby, Christophe Hirtz, et al.
Annals of Neurology|July 17, 2015
Effect of REST on brain metabolism in the Alzheimer disease continuumOriol Dols-Icardo, Eduard Vilaplana, Frederic Sampedro, et al.
Annals of Neurology|June 25, 2013
Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer diseasePetar Podlesniy, Joana Figueiro-Silva, Albert Llado, et al.
Journal of Alzheimer'S Disease : JAD|November 19, 2016
Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Subjects with Down SyndromeMaría Carmona-Iragui, Telma Santos, Sebastián Videla, et al.
Alzheimer Disease and Associated Disorders|October 18, 2011
Rapidly progressive dementia: experience in a tertiary care medical centerIsabel Sala, Marta Marquié, María Belén Sánchez-Saudinós, et al.
Annals of Neurology|January 17, 2014
Reply: To PMID 23794434Petar Podlesniy, Joana Figueiro-Silva, Albert Llado, et al.
BMJ Open Diabetes Research & Care|July 9, 2020
Increased plasma neurofilament light chain levels in patients with type-1 diabetes with impaired awareness of hypoglycemiaFrederic Sampedro, Nicole Stantonyonge, Saül Martínez-Horta, et al.
Pageof 25

Showing results (11-20 of 241) with videos related to

Sort By:
Pageof 25
Alzheimer'S Research & Therapy|October 29, 2023
Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer's disease continuumJulie Goossens, Alba Cervantes González, Nele Dewit, et al.
The Lancet. Healthy Longevity|October 6, 2024
Challenges in the practical implementation of blood biomarkers for Alzheimer's diseaseMichael Schöll, Inge M W Verberk, Marta Del Campo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 6, 2016
Longitudinal brain structural changes in preclinical Alzheimer's diseaseJordi Pegueroles, Eduard Vilaplana, Victor Montal, et al.
Critical Reviews in Clinical Laboratory Sciences|October 30, 2019
Detection of amyloid beta peptides in body fluids for the diagnosis of alzheimer's disease: Where do we stand?Bhavana Veerabhadrappa, Constance Delaby, Christophe Hirtz, et al.
Annals of Neurology|July 17, 2015
Effect of REST on brain metabolism in the Alzheimer disease continuumOriol Dols-Icardo, Eduard Vilaplana, Frederic Sampedro, et al.
Annals of Neurology|June 25, 2013
Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer diseasePetar Podlesniy, Joana Figueiro-Silva, Albert Llado, et al.
Journal of Alzheimer'S Disease : JAD|November 19, 2016
Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Subjects with Down SyndromeMaría Carmona-Iragui, Telma Santos, Sebastián Videla, et al.
Alzheimer Disease and Associated Disorders|October 18, 2011
Rapidly progressive dementia: experience in a tertiary care medical centerIsabel Sala, Marta Marquié, María Belén Sánchez-Saudinós, et al.
Annals of Neurology|January 17, 2014
Reply: To PMID 23794434Petar Podlesniy, Joana Figueiro-Silva, Albert Llado, et al.
BMJ Open Diabetes Research & Care|July 9, 2020
Increased plasma neurofilament light chain levels in patients with type-1 diabetes with impaired awareness of hypoglycemiaFrederic Sampedro, Nicole Stantonyonge, Saül Martínez-Horta, et al.
Pageof 25